• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

40 步脱饱和试验在因 COVID-19 和非 COVID-19 住院患者队列中确定结局的可行性和准确性。

Feasibility and accuracy of the 40-steps desaturation test to determine outcomes in a cohort of patients presenting to hospital with and without COVID-19.

机构信息

Ysbyty Gwynedd, Bangor, UK.

Oxford Brookes University, Oxford, UK.

出版信息

Clin Med (Lond). 2022 May;22(3):203-209. doi: 10.7861/clinmed.2022-0027. Epub 2022 Apr 20.

DOI:10.7861/clinmed.2022-0027
PMID:35443969
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9135085/
Abstract

Desaturation on exercise has been suggested as a predictive feature for deterioration in COVID-19. The objective of this paper was to determine the feasibility and validity for the 40-steps desaturation test.A prospective observational cohort study was undertaken in patients assessed in hospital prior to discharge. One-hundred and fifty-two participants were screened between November 2020 and February 2021, and 64 were recruited to perform a 40-steps desaturation test. Patients who were able to perform the test were younger and less frail. Four patients were readmitted to hospital and one patient deteriorated within 30 days but no patient died.The majority of patients showed little change in saturations during the test, even with pre-existing respiratory pathology. Change in saturations, respiratory rate, heart rate and breathlessness were not predictive of death or readmission to hospital within 30 days. Of 13 patients who had a desaturation of 3% or more during exercise, none was readmitted to hospital within 30 days.Not enough patients with COVID-19 could be recruited to the study to provide evidence for the safety of the test in this patient group.The 40-steps desaturation test requires further evaluation to assess clinical utility.

摘要

运动时血氧饱和度下降被认为是 COVID-19 恶化的预测特征。本文旨在确定 40 步血氧饱和度下降测试的可行性和有效性。

这是一项前瞻性观察队列研究,在出院前评估的患者中进行。2020 年 11 月至 2021 年 2 月期间对 152 名患者进行了筛查,招募了 64 名患者进行 40 步血氧饱和度下降测试。能够进行测试的患者更年轻,身体更健壮。有 4 名患者住院,1 名患者在 30 天内病情恶化,但无患者死亡。

大多数患者在测试过程中血氧饱和度变化不大,即使存在先前存在的呼吸病理学。血氧饱和度、呼吸频率、心率和呼吸困难的变化不能预测 30 天内死亡或再次住院。在 13 名运动时血氧饱和度下降 3%或以上的患者中,无一人在 30 天内再次住院。

由于 COVID-19 患者招募不足,无法为该患者组提供该测试安全性的证据。40 步血氧饱和度下降测试需要进一步评估,以评估其临床效用。

相似文献

1
Feasibility and accuracy of the 40-steps desaturation test to determine outcomes in a cohort of patients presenting to hospital with and without COVID-19.40 步脱饱和试验在因 COVID-19 和非 COVID-19 住院患者队列中确定结局的可行性和准确性。
Clin Med (Lond). 2022 May;22(3):203-209. doi: 10.7861/clinmed.2022-0027. Epub 2022 Apr 20.
2
Direct and indirect evidence of efficacy and safety of rapid exercise tests for exertional desaturation in Covid-19: a rapid systematic review.直接和间接证据表明,快速运动试验对新冠病毒感染所致运动性低氧血症的疗效和安全性:快速系统评价。
Syst Rev. 2021 Mar 16;10(1):77. doi: 10.1186/s13643-021-01620-w.
3
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.评估 BIO101 预防 COVID-19 肺炎患者呼吸恶化的疗效和安全性(COVA 研究):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5.
4
Outpatient treatment of COVID-19 with steroids in the phase of mild pneumonia without the need for admission as an opportunity to modify the course of the disease: A structured summary of a randomised controlled trial.轻症肺炎患者无需住院的情况下使用类固醇进行 COVID-19 门诊治疗作为改变疾病进程的机会:一项随机对照试验的结构化总结。
Trials. 2020 Jul 9;21(1):632. doi: 10.1186/s13063-020-04575-w.
5
Universal screening for SARS-CoV-2 infection: a rapid review.SARS-CoV-2 感染的普遍筛查:快速综述。
Cochrane Database Syst Rev. 2020 Sep 15;9(9):CD013718. doi: 10.1002/14651858.CD013718.
6
SPIKE-1: A Randomised Phase II/III trial in a community setting, assessing use of camostat in reducing the clinical progression of COVID-19 by blocking SARS-CoV-2 Spike protein-initiated membrane fusion.SPIKE-1:一项在社区环境中进行的随机 II/III 期试验,评估了使用卡莫司他通过阻断 SARS-CoV-2 刺突蛋白引发的膜融合来减少 COVID-19 临床进展的效果。
Trials. 2021 Aug 19;22(1):550. doi: 10.1186/s13063-021-05461-9.
7
Care bundles for improving outcomes in patients with COVID-19 or related conditions in intensive care - a rapid scoping review.改善重症监护病房中新冠肺炎患者或相关病症患者预后的综合照护措施——一项快速综述
Cochrane Database Syst Rev. 2020 Dec 21;12(12):CD013819. doi: 10.1002/14651858.CD013819.
8
A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.一项评估 SARS-CoV-2 疫苗(灭活,Vero 细胞)有效性和安全性的随机、双盲、安慰剂对照 III 期临床试验:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Apr 13;22(1):276. doi: 10.1186/s13063-021-05180-1.
9
Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial.评估人抗 SARS-CoV-2 恢复期血浆在 COVID-19 重症成人中的疗效和安全性:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Jun 8;21(1):499. doi: 10.1186/s13063-020-04422-y.
10
Characteristics of COVID-19 Pneumonia Survivors With Resting Normoxemia and Exercise-Induced Desaturation.静息状态下血氧正常和运动诱导性低氧血症的 COVID-19 肺炎幸存者的特征。
Respir Care. 2021 Nov;66(11):1657-1664. doi: 10.4187/respcare.09029. Epub 2021 Aug 24.

引用本文的文献

1
Forty-steps desaturation test does not have prognostic value in COVID-19 due to omicron variant.由于奥密克戎变异株,40步去饱和试验对新冠病毒疾病没有预后价值。
Lung India. 2025 May 1;42(3):270-272. doi: 10.4103/lungindia.lungindia_7_25. Epub 2025 Apr 29.
2
Exercise testing to guide safe discharge from hospital in COVID-19: a scoping review to identify candidate tests.运动试验指导 COVID-19 患者安全出院:一项旨在确定候选试验的范围综述。
BMJ Open. 2023 Oct 31;13(10):e068169. doi: 10.1136/bmjopen-2022-068169.
3
Doing what's necessary becomes doing what is possible.做必要之事,就会成为做可能之事。
Clin Med (Lond). 2022 May;22(3):191. doi: 10.7861/clinmed.ed.22.3.1.

本文引用的文献

1
Direct and indirect evidence of efficacy and safety of rapid exercise tests for exertional desaturation in Covid-19: a rapid systematic review.直接和间接证据表明,快速运动试验对新冠病毒感染所致运动性低氧血症的疗效和安全性:快速系统评价。
Syst Rev. 2021 Mar 16;10(1):77. doi: 10.1186/s13643-021-01620-w.
2
Does Feedback to Physicians of a Patient-Reported Readiness for Discharge Checklist Improve Discharge?向医生反馈患者报告的出院准备情况清单是否能改善出院流程?
J Patient Exp. 2020 Dec;7(6):1144-1150. doi: 10.1177/2374373519895100. Epub 2020 Jan 12.
3
Effects of rapid recruitment and dissemination on Covid-19 mortality: the RECOVERY trial.快速招募和传播对新冠死亡率的影响:RECOVERY 试验。
F1000Res. 2020 Aug 21;9:1017. doi: 10.12688/f1000research.25842.2. eCollection 2020.
4
Silent hypoxaemia in COVID-19 patients.新型冠状病毒肺炎患者的静默性低氧血症。
J Physiol. 2021 Feb;599(4):1057-1065. doi: 10.1113/JP280769. Epub 2021 Jan 4.
5
CALL Score and RAS Score as Predictive Models for Coronavirus Disease 2019.CALL评分和RAS评分作为2019冠状病毒病的预测模型。
Cureus. 2020 Nov 7;12(11):e11368. doi: 10.7759/cureus.11368.
6
Post-exertion oxygen saturation as a prognostic factor for adverse outcome in patients attending the emergency department with suspected COVID-19: a substudy of the PRIEST observational cohort study.运动后血氧饱和度作为疑似 COVID-19 急诊患者不良结局的预后因素:PRIEST 观察性队列研究的亚研究。
Emerg Med J. 2021 Feb;38(2):88-93. doi: 10.1136/emermed-2020-210528. Epub 2020 Dec 3.
7
Silent hypoxia in patients with SARS CoV-2 infection before hospital discharge.SARS CoV-2 感染患者出院前的静默性低血氧症。
Int J Infect Dis. 2020 Oct;99:100-101. doi: 10.1016/j.ijid.2020.07.014. Epub 2020 Jul 11.
8
Early Detection of Silent Hypoxia in Covid-19 Pneumonia Using Smartphone Pulse Oximetry.使用智能手机脉搏血氧仪早期检测新冠病毒肺炎中的沉默性低氧血症
J Med Syst. 2020 Jun 19;44(8):134. doi: 10.1007/s10916-020-01587-6.
9
Why COVID-19 Silent Hypoxemia Is Baffling to Physicians.为什么 COVID-19 静默性低氧血症让医生感到困惑。
Am J Respir Crit Care Med. 2020 Aug 1;202(3):356-360. doi: 10.1164/rccm.202006-2157CP.
10
Lactate dehydrogenase and susceptibility to deterioration of mild COVID-19 patients: a multicenter nested case-control study.乳酸脱氢酶与轻症 COVID-19 患者病情恶化易感性的关系:一项多中心巢式病例对照研究。
BMC Med. 2020 Jun 3;18(1):168. doi: 10.1186/s12916-020-01633-7.